Prostatic stromal sarcoma: Case report and review of the literature

Pathology International

Volumn 53, Issue 6, 2003, Pages 407-411

  Osaki, Mari ^a   Osaki, Mitsuhiko ^a   Takahashi, Chihiro ^b   Miyagawa, Tetsuo ^c   Adachi, Hironobu ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Yonago National Hospital   (Japan)

^c Miyagawa Clinic   (Japan)

Author keywords

Immunohistochemistry; Prostate; Stromal sarcoma

Indexed keywords

CD34 ANTIGEN; CYTOKERATIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR MARKER; TUMOR PROTEIN; VIMENTIN;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CELL NUCLEUS; CHEMISTRY; ENZYME IMMUNOASSAY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PATHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE STROMAL SARCOMA; PROSTATE TUMOR; PROSTATECTOMY; SARCOMA; STROMA CELL; TREATMENT OUTCOME; TUMOR CELL; TUMOR DIFFERENTIATION;

AGED; ANTIGENS, CD34; CELL NUCLEUS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; RECEPTORS, PROGESTERONE; SARCOMA; STROMAL CELLS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 0038824840     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01489.x     Document Type: Article

References (16)

1. Gaudin PB, Rosai J, Epstein JI. Sarcomas and related proliferative lesions of specialized prostatic stroma. Am J Surg Pathol 1998; 22: 148-62.
2. Lindenmayer AE, Miettinen M. Immunophenotypic features of uterine stromal cells. CD34 expression in endocervical stroma. Virchows Arch 1995; 426: 457-60.
3. Bernard T, John RS, Bostwick DG. Soft tissue tumors. In: Bostwick GB, ed. Pathology of the Prostate. New York: Churchill Livingstone, 1990; 117-35.
4. Bostwick DG, Eble JN. Neoplasms of the prostate. In: Bostwick DG, Eble JN, eds. Urologic Surgical Pathology. Philadelphia: Mosby, 1997; 399-401.
5. Gueft B, Walsh MA, Malignant prostatic cystosarcoma phyllodes. NY State J Med 1975; 75: 2226-8.
6. Kerley SW, Pierce P, Thomas J. Giant cystosarcoma phyllodes of the prostate associated with adenocarcinoma. Arch Pathol Lab Med 1992; 116: 195-7.
7. Manivel C, Shenoy BV, Wick MR, Dehner LP. Cystosarcoma phyllodes of the prostate: a pathologic and immunohistochemical study. Arch Pathol Lab Med 1986; 110: 534-8.
8. Yokota T, Yamashita Y, Okuzono Y et al. Malignant cystosarcoma phyllodes of the prostate. Acta Pathol Jpn 1984; 34: 663-8.
9. Ito H, Ito M, Mitsuhara N, Tahara E. Phyllodes tumor of the prostate: a case report. Jpn J Clin Oncol 1989; 19: 299-304.
10. Lopez-Beltran A, Gaeta JF, Huben R, Croghan GA. Malignant phyllodes tumor of prostate. Urology 1990; 35: 164-7.
11. Young JF, Jensen PE, Wiley CA. Malignant phyllodes tumor of the prostate. Arch Pathol Lab Med 1992; 116: 296-9.
12. Yum M, Miller JC, Agrawal BL. Leiomyosarcoma arising in atypical fibromuscular hyperplasia (phyllodes tumor) of the prostate with distant metastasis. Cancer 1991; 68: 910-15.
13. Attah EB, Powell ME. Atypical stromal hyperplasia of the prostate gland. Am J Clin Pathol 1977; 67: 324-7.
14. Probert JL, O'Rourke JS, Farrow R, Cox P. Stromal sarcoma of the prostate. Eur J Surg Oncol 2000; 26: 100-1.
15. Kevwitch MK, Walloch JL, Waters WB, Flanigan RC. Prostatic cystic epithelial-stromal tumors, a report of 2 new cases. J Urol 1993; 149: 860-64.
16. Rao BR, Meyer JS, Fry CG. Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but luck estrogen receptor: stromal localization of progesterone receptor. Cancer 1981; 47: 2016-111.